TRVI
Trevi Therapeutics Inc.
Company Overview
| Mkt Cap | $1.28B | Price | $11.66 |
| Volume | 1.90M | Change | +4.39% |
| P/E Ratio | -26.7 | Open | $11.16 |
| Revenue | -- | Prev Close | $11.17 |
| Net Income | $-47.9M | 52W Range | $2.36 - $11.68 |
| Div Yield | N/A | Target | $20.36 |
| Overall | 60 | Value | 45 |
| Quality | 47 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyTrevi Therapeutics Inc. (TRVI) is a leading Healthcare company in the Biotechnology industry, currently trading at $11.66 with a market capitalization of $1.28 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 47.
Today's trading session shows TRVI with a volume of 1.90 million shares. The stock opened down 0.09% from yesterday's close of $11.17. Current analyst estimates project earnings of $-0.39 per share for this year, with next year targeting $-0.54.
TRVI demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for TRVI include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 74.6%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:18 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRVI | $11.66 | +4.4% | 1.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |